One block west of the
National Theater on Avenida Segunda (2nd Avenue), SAN
JOSE, COSTA RICA
Tel+506 233-6380,+506 223-1715, Fax+506 233-9869 - firstname.lastname@example.org
Professional service in a friendly
and courteous environment...
Isoprinosine is the main product of
Newport Pharmaceuticals of Costa Rica. The active ingredient identified in the
pharmacopoeias is Methisoprinol (Inosine Pranobex). It is a non-toxic immune system
stimulant prescribed in the treatment of numerous viral illnesses including herpes
simplex, hepatitis, eruptive diseases of infancy and other viral afflictions related with
Pharmacy Customer Service...
is our Competitive Edge
The drug has demonstrated clinical
activity against influenza symptoms, common cold, viral encephalitis, herpes and severe
manifestations of immunodeficiencies. Besides, it is a non-toxic drug with an excellent
record of clinical security in short and long term therapeutic treatments.
Newport pharmaceuticals, along the
years, has published more than one thousand seven-hundred and fifty clinical studies about
ISOPRINOSINE. Some have been published in scientific magazines of excellent reputation
such as the New England Journal of Medicine and Lancet.
- Methisoprinol was patented in the United States in
1969. Later, to protect the companys intellectual property, the patent was
registered in sixty-two countries.
- Isoprinosine is an immunestimulant drug prescribed
for the treatment of several viral diseases including herpes simplex, Herpes Zoster, viral
hepatitis, childhood eruptive diseases, and other viral infections that occur with
- In 1982 Isoprinosine received in France the renown
"Le Prix Galien". At that time, Isoprinosine was considered the main therapeutic
innovation introduced in the French market.
The clinical studies on ISOPRINOSINE have been
conducted by independent scientists and doctors at prestigious research centers in the
United States and Europe.
The following therapeutic indications have abundant
scientific support in published clinical studies:
In June of 1990, it was published in
the New England Journal of Medicine the double blind clinical study called "The
efficacy of Pranobex in the prevention of the Acquired immunodefieiency Syndrome in
patients infected by the virus of human immunodeficiency". It included eight-hundred
and sixty-six patients, who had not completely developed AIDS. The investigation was
carried out in twenty-one distinguished hospitals of Sweden and Denmark. The technical
conclusion was : Isoprinosine delays the onset of AIDS in patients
infected with HIV virus.
- Primary and secondary breathing infections in adults
- Hepatitis and immunodepression
- Labial herpes, genital herpes, Keratis Herpes, Herpes
- Chicken pox
- Citomegalovirus and Epstein Bar infection
- Subacute sclerosing panencephalitis
Dr. Rodrigo Zavaleta, our resident pharmacologist at Farmacia Sucre, is always available to discuss your pharmaceutical
needs... and, to review any health issues that may be of concern to you.
| Farmacia Sucre homepage |